ARCHIVES

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 04 | February 5, 2010

Download PDF Visit The Full Archive

Related Articles

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Republican Congress To Shift Priorities, But Cancer May Get New Opportunities

November 18, 1994

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines?

March 19, 2004

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981